Prohance Multipack

Active Ingredient(s): Gadoteridol
FDA Approved: * October 9, 2003
Pharm Company: * BRACCO
Category: Diagnostic Aid

Gadoteridol (INN) is a gadolinium-based MRI contrast agent, used particularly in the imaging of the central nervous system. It is sold under the brand name ProHance. References .mw-parser-output cite.citation{font-style:inherit;word-wrap:break-word}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .citation:target{background-color:rgba(0,127,255,0.133)}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background:linear-gradient(transparent,t... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Prohance 279.3 mg/ml Intravenous Injection, Solution
NDC: 0270-1111
Bracco Diagnostics Inc.